Robert Probst (EVP/CFO) exercised 29,691 options; sold shares under 10b5-1 plan
Rhea-AI Filing Summary
Reporting person: Robert F. Probst, EVP and CFO of Ventas, Inc. (VTR). Transaction date: 08/04/2025; Form filed: 08/06/2025.
Actions: Probst exercised 29,691 fully vested stock options at an exercise price of $65.45 and sold 29,691 underlying shares pursuant to a Rule 10b5-1 trading plan entered on 02/19/2025. The shares were sold in multiple transactions at prices ranging $68.45–$68.5563 with a weighted average sale price of $68.4917.
Post-transaction position: Beneficial ownership reported as 168,364 shares held directly; 33,591 unexercised options remain (expiration 05/04/2026).
Positive
- Transaction executed under a Rule 10b5-1 trading plan entered on 02/19/2025
- Exercised fully vested options (29,691) rather than granted or newly issued options
- Form 4 filed promptly and signed by attorney-in-fact on 08/06/2025
Negative
- Sold 29,691 shares, reducing direct beneficial ownership from 198,055 to 168,364 as reported
- Unexercised options scheduled to expire within ~9 months (33,591 options, expiration 05/04/2026)
- Shares sold (prices ranged $68.45–$68.5563) which decreases insider's direct stake
Insights
TL;DR: Insider exercised 29,691 options and immediately sold the same number of shares under a 10b5-1 plan on 08/04/2025.
Detailed analysis: The filing shows an exercise of 29,691 fully vested options at $65.45 and contemporaneous sale of 29,691 shares at weighted avg $68.4917. The transaction was executed pursuant to a Rule 10b5-1 plan dated 02/19/2025. Post-transaction direct beneficial ownership declined to 168,364 shares and 33,591 unexercised options remain, expiring 05/04/2026. This is a routine, pre-planned option exercise and sale; it clarifies positions but does not itself report corporate operational metrics.
TL;DR: Transaction executed under a documented 10b5-1 plan; Form 4 filed and signed by attorney-in-fact two days after the trade.
Detailed analysis: The disclosure states the trades were conducted under a Rule 10b5-1 trading plan entered on 02/19/2025, and the Form 4 bears a signature dated 08/06/2025. The options exercised were fully vested and scheduled to expire within the next nine months, and the filer provides a footnote offering to supply per-price sale breakdowns on request. From a governance/compliance perspective, the filing documents adherence to an affirmative defense plan and timely reporting.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 29,691 | $0.00 | -- |
| Exercise | Common Stock | 29,691 | $65.45 | $1.94M |
| Sale | Common Stock | 29,691 | $68.4917 | $2.03M |
Footnotes (1)
- The transaction involved the exercise of fully vested options scheduled to expire in the next 9 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on February 19, 2025. The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $68.45 to $68.5563, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Fully vested. Represents total number of unexercised options to purchase shares of Issuer's Common Stock held by the Reporting Person.
